Potential of osteopontin in the management of epithelial ovarian cancer

Abstract

Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.

Keywords

• advanced ovarian cancer
• osteopontin
• serum
• ascites